MWA CONSULTING, INC.
  • Home
  • About AVS Life Sciences (formerly MWA Consulting)
  • Consulting Services
  • Industry News
  • Resource Center
    • Webinars
    • Blogs
    • Podcasts
  • Consulting Opportunities
  • Contact Us
  • Privacy Policy
Select Page

FDA Announces Availability of Portal and draft Guidance on Reporting Amount of Listed Drugs and Biological Products

Oct 29, 2021

FDA has announced the new use of a NextGen Portal for reporting the annual amount of listed human and animal drugs and human biological products that an establishment manufactured, prepared, propagated, compounded, or processed (including repacking and relabeling) for...

Stay current with FDA regulatory news and compliance trends!

Follow MWA on LinkedIn:

Recent Posts

  • The top 8 pharmaceutical consulting firms you should consider for 2024
  • AVS-MWA among Qualio’s 9 top medical device consulting firms you should consider for 2024
  • Accelerating Batch Record Reviews With Electronic Batch Records
  • FDA Guidance Document Regarding Quality Considerations for Ophthalmic Drug Products
  • FDA Launches New Webpage for Searching Pharmaceutical Quality Documents

Designed by Elegant Themes | Powered by WordPress